Milliman Report on Value-Based Design and Diabetes

Kathryn Fitch and the team at Milliman have produced this excellent report on the state of the value-based healthcare movement as it relates to diabetes management.  The analysis quantifies the projected costs associated with implementing VBID for diabetes drugs. Read the full report.

Tags: , , ,

This entry was posted on Tuesday, July 21st, 2009 at 9:49 am and is filed under Market Analysis, News Room. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.